Filter
349
Filtered Results: 349
Text search:
GMP
Featured
Recommendations
41
New Publications
102
Language
Document type
No document type
175
Guidelines
67
Studies & Reports
46
Manuals
30
Strategic & Response Plan
13
Fact sheets
8
Training Material
6
Situation Updates
4
Countries / Regions
India
17
Nepal
14
Kenya
14
Ethiopia
13
Uganda
10
Sierra Leone
9
Nigeria
9
Global
9
Zambia
9
Tanzania
8
South Africa
7
Namibia
7
Liberia
7
Ghana
6
Western and Central Europe
6
Zimbabwe
5
Bangladesh
5
Africa
4
Germany
4
Middle East and North Africa
4
Botswana
4
Indonesia
4
Rwanda
3
Philippines
3
Latin America and the Carribbean
3
South–East Asia Region
3
Russia
3
South Sudan
3
Tajikistan
2
Colombia
2
Syria
2
Senegal
2
Malawi
2
Eastern Europe and Central Asia
2
Eastern Europe
2
Brazil
2
Yemen
2
Myanmar / Burma
2
Eswatini/ Swaziland
2
Thailand
1
Ukraine
1
Lesotho
1
Cameroon
1
Iran
1
Albania
1
Laos
1
Burkina Faso
1
Guinea
1
Mozambique
1
Cambodia
1
Guinea-Bissau
1
Jordan
1
Congo, Democratic Republic of
1
West and Central Africa
1
Western Pacific Region
1
Turkmenistan
1
Maldives
1
United Kingdom
1
Spain
1
East and Southern Africa
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Sri Lanka
1
Mali
1
Angola
1
Bhutan
1
Somalia
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
161
Clinical Guidelines
48
Public Health
25
Pharmacy & Technologies
25
Capacity Building
11
Women & Child Health
11
Key Resources
11
Toolboxes
Pharmacy
40
AMR
36
COVID-19
25
Planetary Health
15
TB
14
Rapid Response
8
NTDs
8
Ebola
7
Refugee
4
Zika
4
Global Health Education
4
Natural Hazards
3
HIV
2
Conflict
2
Cholera
1
Caregiver
1
Health Financing Toolbox
1
NCDs
1
Polio
1
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
L’objectif de cette note conceptuelle et du cadre dont elle donne les grandes lignes est l’élimination d’un groupe de MT et de leurs effets pénalisants sur la santé (maladies énumérées au tableau 1 ci-dessous) qui, pris globalement, génèrent une charge tangible pour les personnes touch...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The publication of the of the Antimicrobial Treatment Guidelines represents the
culmination of the efforts of the Antimicrobial Stewardship Program of ICMR to publish treatment guidelines for common syndromes in India. These guidelines are targeted for the health care settings. It aims to rationali...
This report describes the activities of the WHO European Centre for Primary Health Care in 2022.The Centre accelerated face-to-face country support after the wake of the COVID-19 pandemic to support countries in engaging in analysis and diagnosis, developing strategies and policies, building capacit...
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to health facilities or a qualified health care provider and do not receive the necessary care in a...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner drug ...
This document serves to provide interim guidance/ recommendations to carry out mpox surveillance activities mainly case investigation, contact tracing and isolation. For the development of this document WHO, UKHSA and CDC guidelines were referred to and adopted within the country context.
